Stem Cell Therapy: A Breakthrough Against MS?
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - January 22, 2021 Category: Consumer Health News Source Type: news

Foods to Avoid When You Have MS
Could skipping certain foods help you manage symptoms of multiple sclerosis (MS)? Experts say that paying close attention to what you eat does play a key role in managing MS and your overall health. (Source: WebMD Health)
Source: WebMD Health - January 21, 2021 Category: Consumer Health News Source Type: news

Could Stem Cell Therapy Be a Breakthrough Against MS?
  THURSDAY, Jan. 21, 2021 -- Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests. Italian researchers found that among 210 multiple sclerosis (MS) patients who... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 21, 2021 Category: General Medicine Source Type: news

Stem Cell Transplant May Slow Disability in Multiple Sclerosis
THURSDAY, Jan. 21, 2021 -- For patients with multiple sclerosis (MS), autologous hematopoietic stem cell transplantation (aHSCT) may prevent worsening of disability, according to a study published online Jan. 20 in Neurology. Giacomo Boffa, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2021 Category: Pharmaceuticals Source Type: news

5 Updates in Neurology 5 Updates in Neurology
Dr Christoph Diener highlights new evidence on subdural hematoma, traumatic brain injury, COVID-19, seizure, and multiple sclerosis.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 20, 2021 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

Fatty acid may help combat multiple sclerosis
A lack of oleic acid in the body ’s fatty tissue may trigger the immune system response that causes multiple sclerosis, suggesting a possible dietary treatment. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 19, 2021 Category: Universities & Medical Training Source Type: news

Fatty acid may help combat multiple sclerosis
(Yale University) The abnormal immune system response that causes multiple sclerosis (MS) by attacking and damaging the central nervous system can be triggered by the lack of a specific fatty acid in fat tissue, according to a new Yale study. The finding suggests that dietary change might help treat some people with the autoimmune disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 19, 2021 Category: International Medicine & Public Health Source Type: news

Kessler Foundation studies effects of Tysabri on cognitive fatigue in multiple sclerosis
(Kessler Foundation) The majority of persons with MS have cognitive fatigue, which can adversely affect their ability to perform everyday life activities. Although 40% consider cognitive fatigue their most troubling symptom, there are few treatment options. None of the pharmacological interventions used to slow progression of physical disability are indicated for treating cognitive fatigue. This is the first study to explore whether treatment with Tysabri may alleviate cognitive fatigue in individuals with MS. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 19, 2021 Category: International Medicine & Public Health Source Type: news

Emotional Support Animals for MS
Emotional support animals are more than just pets. If you have multiple sclerosis, they can provide emotional comfort and sometimes perform useful tasks. Learn what sets them apart from service animals and therapy dogs. (Source: WebMD Health)
Source: WebMD Health - January 15, 2021 Category: Consumer Health News Source Type: news

Does MS Affect Your Life Expectancy?
Can multiple sclerosis affect how long you live? Does the type you have make a difference? Learn more about life expectancy with this condition. (Source: WebMD Health)
Source: WebMD Health - January 15, 2021 Category: Consumer Health News Source Type: news

T cells linked to myelin implicated in MS-like disease in monkeys
(Oregon Health& Science University) Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people. By linking two specific T cells to the loss of myelin, scientists say the new study opens the possibility of developing an antiviral therapy that could be especially useful for newly diagnosed cases of multiple sclerosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2021 Category: International Medicine & Public Health Source Type: news

COVID-19 Vaccine Shots Begin at Disneyland (CA) Parking Lot
Ian Wheeler and Dan Albano The Orange County Register (MCT) Cars and socially spaced crowds amassed at Disneyland’s Toy Story parking lot Wednesday, Jan. 13, as hundreds queued for coronavirus vaccines at Orange County’s first mass-vaccination site, a pivotal step toward county leaders’ new goal of delivering 1.5 million shots per month. The tented site’s opening marks a new chapter in Orange County’s battle against the coronavirus as people age 65 and older, especially those who have underlying health conditions that might make them more susceptible to a bad case of COVID-19, can ...
Source: JEMS Patient Care - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed California Medicine Source Type: news

COVID-19 Vaccine Shots Begin at Disneyland (CA) Parking Lot
Ian Wheeler and Dan Albano The Orange County Register (MCT) Cars and socially spaced crowds amassed at Disneyland’s Toy Story parking lot Wednesday, Jan. 13, as hundreds queued for coronavirus vaccines at Orange County’s first mass-vaccination site, a pivotal step toward county leaders’ new goal of delivering 1.5 million shots per month. The tented site’s opening marks a new chapter in Orange County’s battle against the coronavirus as people age 65 and older, especially those who have underlying health conditions that might make them more susceptible to a bad case of COVID-19, can ...
Source: JEMS Administration and Leadership - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed California Medicine Source Type: news

COVID-19 Vaccine Shots Begin at Disneyland (CA) Parking Lot
Ian Wheeler and Dan Albano The Orange County Register (MCT) Cars and socially spaced crowds amassed at Disneyland’s Toy Story parking lot Wednesday, Jan. 13, as hundreds queued for coronavirus vaccines at Orange County’s first mass-vaccination site, a pivotal step toward county leaders’ new goal of delivering 1.5 million shots per month. The tented site’s opening marks a new chapter in Orange County’s battle against the coronavirus as people age 65 and older, especially those who have underlying health conditions that might make them more susceptible to a bad case of COVID-19, can ...
Source: JEMS Latest News - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed California Medicine Source Type: news

COVID-19 Vaccine Shots Begin at Disneyland (CA) Parking Lot
Ian Wheeler and Dan Albano The Orange County Register (MCT) Cars and socially spaced crowds amassed at Disneyland’s Toy Story parking lot Wednesday, Jan. 13, as hundreds queued for coronavirus vaccines at Orange County’s first mass-vaccination site, a pivotal step toward county leaders’ new goal of delivering 1.5 million shots per month. The tented site’s opening marks a new chapter in Orange County’s battle against the coronavirus as people age 65 and older, especially those who have underlying health conditions that might make them more susceptible to a bad case of COVID-19, can ...
Source: JEMS: Journal of Emergency Medical Services News - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed California Medicine Source Type: news

COVID-19 Vaccine Shots Begin at Disneyland (CA) Parking Lot
Ian Wheeler and Dan Albano The Orange County Register (MCT) Cars and socially spaced crowds amassed at Disneyland’s Toy Story parking lot Wednesday, Jan. 13, as hundreds queued for coronavirus vaccines at Orange County’s first mass-vaccination site, a pivotal step toward county leaders’ new goal of delivering 1.5 million shots per month. The tented site’s opening marks a new chapter in Orange County’s battle against the coronavirus as people age 65 and older, especially those who have underlying health conditions that might make them more susceptible to a bad case of COVID-19, can ...
Source: JEMS Operations - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed California Medicine Source Type: news

COVID-19 Vaccine Shots Begin at Disneyland (CA) Parking Lot
Ian Wheeler and Dan Albano The Orange County Register (MCT) Cars and socially spaced crowds amassed at Disneyland’s Toy Story parking lot Wednesday, Jan. 13, as hundreds queued for coronavirus vaccines at Orange County’s first mass-vaccination site, a pivotal step toward county leaders’ new goal of delivering 1.5 million shots per month. The tented site’s opening marks a new chapter in Orange County’s battle against the coronavirus as people age 65 and older, especially those who have underlying health conditions that might make them more susceptible to a bad case of COVID-19, can ...
Source: JEMS Special Topics - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed California Medicine Source Type: news

Mass trial of repurposed MS drug for Covid begins at hospital in Hull
A mass trial of a repurposed Multiple Sclerosis drug that researchers hope will hugely reduce the chances of coronavirus patients becoming seriously ill has begun at a hospital in Hull. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2021 Category: Consumer Health News Source Type: news

Pregnancy Outcomes Examined for Women With Multiple Sclerosis
WEDNESDAY, Jan. 13, 2021 -- Women with pregnancy after versus before a multiple sclerosis (MS) diagnosis have fewer children and at an older age, according to a study published in the Feb. 1 issue of Multiple Sclerosis and Related... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2021 Category: Pharmaceuticals Source Type: news

Falls in people with multiple sclerosis: risk identification, intervention, and future directions - Coote S, Comber L, Quinn G, Santoyo-Medina C, Kalron A, Gunn H.
Falls are highly prevalent in people with multiple sclerosis (MS) and result in a range of negative consequences, such as injury, activity curtailment, reduced quality of life, and increased need for care and time off work. This narrative review aims to su... (Source: SafetyLit)
Source: SafetyLit - January 13, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Effectiveness of non-pharmacological falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke: protocol for an umbrella review - O'Malley N, Clifford AM, Comber L, Coote S.
BACKGROUND: Falls are common among people with neurological diseases and have many negative physical, psychosocial and economic consequences. Implementation of single-diagnosis falls prevention interventions is currently problematic due to lack of partic... (Source: SafetyLit)
Source: SafetyLit - January 7, 2021 Category: International Medicine & Public Health Tags: Falls Source Type: news

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
The ability to control autoreactive T cells without inducing systemic immune suppression is the major goal for treatment of autoimmune diseases. The key challenge is the safe and efficient delivery of pharmaceutically well-defined antigens in a noninflammatory context. Here, we show that systemic delivery of nanoparticle-formulated 1 methylpseudouridine-modified messenger RNA (m1 mRNA) coding for disease-related autoantigens results in antigen presentation on splenic CD11c+ antigen-presenting cells in the absence of costimulatory signals. In several mouse models of multiple sclerosis, the disease is suppressed by treatment...
Source: ScienceNOW - January 7, 2021 Category: Science Authors: Krienke, C., Kolb, L., Diken, E., Streuber, M., Kirchhoff, S., Bukur, T., Akilli-Öztürk, O., Kranz, L. M., Berger, H., Petschenka, J., Diken, M., Kreiter, S., Yogev, N., Waisman, A., Kariko, K., Türeci, O., Sahin, U. Tags: Immunology, Medicine, Diseases r-articles Source Type: news

A new approach to study autoimmune diseases
This study, " Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis and rheumatoid arthritis, " is featured in the Jan. 6, 2021, edition ofScience Advances. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2021 Category: International Medicine & Public Health Source Type: news

The Feverish Pricing of MS Treatments
Towards the end of March, the FDA approved two new treatments for multiple sclerosis (MS): Mayzent (siponimod) and Mavenclad (cladribine). Both represent important breakthroughs for people with certain types of MS. But they come at a cost. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 30, 2020 Category: General Medicine Source Type: news

Which Imaging Criteria Identify Progressive Forms of MS? Which Imaging Criteria Identify Progressive Forms of MS?
The role of imaging in diagnosing progressive multiple sclerosis and in assessing prognosis is the subject of a new review.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 30, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Cardiovascular autonomic dysfunction and falls in people with multiple sclerosis: is there a link? An opinion article - Zanotto T, Hernandez ME, Medrano CN, Wilund KR, Sosnoff JJ.
Falls and fall-related injuries are highly prevalent in people living with multiple sclerosis (MS). A multinational meta-analysis revealed that 56% of people with MS (pwMS) fall at least once in any 3-month period (Nilsag ård et al., 2015) and 11-42% of fa... (Source: SafetyLit)
Source: SafetyLit - December 30, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Is Multiple Sclerosis MS Contagious
Is Multiple Sclerosis (MS) Contagious? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 22, 2020 Category: General Medicine Source Type: news

Researchers explore why some MS patients experience seizures
(University of California - Riverside) A research team at the UC Riverside School of Medicine has identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures happen in a subset of multiple sclerosis, or MS, patients. The finding improves scientific understanding of how seizures arise in MS and could provide the foundation for better therapies to manage treatment-resistant seizures in MS and other brain diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 21, 2020 Category: Biology Source Type: news

Risk factors for falling for people with multiple sclerosis identified in a prospective cohort study - Quinn G, Comber L, McGuigan C, Hannigan A, Galvin R, Coote S.
OBJECTIVE: To identify risk factors for falling for people with Multiple Sclerosis. DESIGN: Prospective cohort study. SETTING: Neurology service in a tertiary hospital. SUBJECTS: Participants were 101 people with Multiple Sclerosis and Expanded... (Source: SafetyLit)
Source: SafetyLit - December 18, 2020 Category: International Medicine & Public Health Tags: Falls Source Type: news

Caroline Wyatt: MS research 'the urgent search for hope'
The BBC's Caroline Wyatt looks at what medical advances might bring for people with multiple sclerosis. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 18, 2020 Category: Consumer Health News Source Type: news

Biogen to Pay $22 Million to Resolve US  Drug Charity Kickback Probe Biogen to Pay $22 Million to Resolve US  Drug Charity Kickback Probe
Biogen Inc has agreed to pay $22 million to resolve US allegations that it illegally used two charities that help cover Medicare patients'out-of-pocket drug costs as a means to pay them kickbacks to use its multiple sclerosis drugs.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Effect of Siponimod on Cognition in MS Patients Explored
Mixed results seen for effect of siponimod on cognitive processing speed in patients with secondary progressive multiple sclerosis (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - December 17, 2020 Category: Psychiatry Tags: Neurology, Pharmacy, Psychiatry, Journal, Source Type: news

U-turn speed is a valid and reliable smartphone-based measure of multiple sclerosis-related gait and balance impairment - Cheng WY, Bourke AK, Lipsmeier F, Bernasconi C, Belachew S, Gossens C, Graves JS, Montalban X, Lindemann M.
BACKGROUND: People living with multiple sclerosis (MS) experience impairments in gait and mobility, that are not fully captured with manually timed walking tests or rating scales administered during periodic clinical visits. We have developed a smartphone-... (Source: SafetyLit)
Source: SafetyLit - December 17, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Effect of Siponimod on Cognition in MS Patients Explored
THURSDAY, Dec. 17, 2020 -- Some cognitive tests but not others suggest siponimod may speed cognitive processing in patients with secondary progressive (SP) multiple sclerosis (MS), according to a study published online Dec. 16 in Neurology. Ralph... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 17, 2020 Category: Pharmaceuticals Source Type: news

Siponimod Improves Cognition in Advanced Multiple Sclerosis Siponimod Improves Cognition in Advanced Multiple Sclerosis
Spionimod, a second-generation MS drug, achieves clinically meaningful improvement in cognitive processing speed for patients with advanced disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 17, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Siponimod May Boost Thinking Skills in People With Advanced MS
WEDNESDAY, Dec. 16, 2020 -- Researchers say a multiple sclerosis drug meant to slow physical disability also shows promise in improving mental acuity in people who are living with secondary progressive MS, an advanced form of the disease. The new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 16, 2020 Category: General Medicine Source Type: news

Drug May Boost Thinking Skills in People With Advanced MS
WEDNESDAY, Dec. 16, 2020 -- Researchers say a multiple sclerosis drug meant to slow physical disability also shows promise in improving mental acuity in people who are living with secondary progressive MS, an advanced form of the disease. The new... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 16, 2020 Category: General Medicine Source Type: news

FDA Approves Genentech ’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis
South San Francisco, CA -- December 14, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 14, 2020 Category: Drugs & Pharmacology Source Type: news

FDA approves Roche ’s OCREVUS® (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis
Basel, 14 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for OCREVUS ® (ocrelizumab), dosed twice-yearly for those living with relapsing or primary progressive multiple sclerosis (MS) who have not experienced any prior serious infusion reactions (IRs). The approval was based on data from the randomised, double-blind ENSEMBLE PLUS study.“More than 170,000 people with MS have been treated with OCREVUS - the only approved B-cell therapy with a twice-yearly dosing schedule - and it is the most prescribed...
Source: Roche Media News - December 14, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s OCREVUS® (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis
Basel, 14 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for OCREVUS ® (ocrelizumab), dosed twice-yearly for those living with relapsing or primary progressive multiple sclerosis (MS) who have not experienced any prior serious infusion reactions (IRs). The approval was based on data from the randomised, double-blind ENSEMBLE PLUS study.“More than 170,000 people with MS have been treated with OCREVUS - the only approved B-cell therapy with a twice-yearly dosing schedule - and it is the most prescribed...
Source: Roche Investor Update - December 14, 2020 Category: Pharmaceuticals Source Type: news

Dating With MS
Multiple sclerosis (MS) can make dating more challenging. Learn how to find the right person for you, and how to reveal your diagnosis to them. (Source: WebMD Health)
Source: WebMD Health - December 11, 2020 Category: Consumer Health News Source Type: news

Can an App Help You Manage MS?
You’ll find tons of apps for multiple sclerosis, but they won’t all suit your needs. Here’s how to choose the right MS app for you, whether you want a serious tool to monitor your health or useful app to help you stay on top of your medications and appointments. (Source: WebMD Health)
Source: WebMD Health - December 11, 2020 Category: Consumer Health News Source Type: news

Bernie Marcus giving $80 million to Shepherd Center
Atlanta philanthropist and Home Depot co-founder Bernie Marcus and his wife are giving $80 million to Atlanta's Shepherd Center. The grant from The Marcus Foundation, announced today, is the largest in Shepherd Center's history and will be the cornerstone of the specialty rehabilitation hospital’s most significant, transformational expansion since its founding in 1975. Shepherd Center is a nationally-ranked hospital for patients with spinal cord injury, brain injury, stroke, multiple sclerosis,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2020 Category: Pharmaceuticals Source Type: news

National Multiple Sclerosis Society funds neuroimaging study of memory dysfunction in MS
(Kessler Foundation) " To our knowledge, this is the first investigation to utilize a strong translational approach to begin to pinpoint the interrelationship of working memory, brain functioning, and long-term memory problems in MS, " said Dr. Dobryakova. " This cutting-edge research may provide a strong foundation to our understanding of memory loss, and lead to effective interventions for restoring lost function. " (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2020 Category: International Medicine & Public Health Source Type: news

MS: Essex woman says she is 'determined' after diagnosis
Danielle Thorburn, 29, sees her multiple sclerosis diagnosis as a "challenge" to achieve her goals. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 9, 2020 Category: Consumer Health News Source Type: news

Automated detection of real-world falls: modeled from people with multiple sclerosis - Mosquera-Lopez C, Wan E, Shastry M, Folsom J, Leitschuh J, Condon J, Rajhbeharrysingh U, Hildebrand A, Cameron MH, Jacobs PG.
Falls are a major health problem with one in three people over the age of 65 falling each year, oftentimes causing hip fractures, disability, reduced mobility, hospitalization and death. A major limitation in fall detection algorithm development is an abse... (Source: SafetyLit)
Source: SafetyLit - December 5, 2020 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

COVID-19 Vaccines Coming Soon – When Can I Get One?
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p6").init({"mcp":"cbs","width":"100%","height":"100%","video":"4920382","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p6","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 1, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Covid-19 Boston, MA Healthcare Status Coronavirus Coronavirus Vaccine Moderna Moderna Therapeutics Source Type: news

Socioeconomic benefits of ocrelizumab for multiple sclerosis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2020 Category: Drugs & Pharmacology Source Type: news

Breast Cancer, CRC Incidence No Different With, Without MS
However, bladder cancer incidence and mortality rates higher among individuals with multiple sclerosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 30, 2020 Category: Cancer & Oncology Tags: Gastroenterology, Gynecology, Internal Medicine, Neurology, Oncology, Urology, Journal, Source Type: news